Cerebral Autoregulation in Patients With Aneurysmal SubArachnoid Haemorrhage
CASAH
1 other identifier
interventional
45
1 country
1
Brief Summary
The purpose is, in patients with aneurysmal subarachnoid haemorrhage in the early phase after ictus, to examine the following:
- 1.The effect of spontaneous and induced changes on the brain's static and dynamic autoregulation calculated by transcranial Doppler (TCD), ICP and MAP (primary purposes) and ICP and PbtO2;
- 2.The effect of mild hyper- and hypocapnia as well as of mild hyper- and hypoxia on the brain's static and dynamic autoregulation, ICP and PbtO2;
- 3.The relationship between brain autoregulation, mild hyper- and hypocapnia, as well as of mild hyper- and hypoxia and metabolism in microdialysate on the one hand and the occurrence of DCI during hospitalization and poor neurological outcome one year after ictus on the other.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 11, 2019
CompletedFirst Posted
Study publicly available on registry
June 14, 2019
CompletedStudy Start
First participant enrolled
June 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2022
CompletedOctober 29, 2021
October 1, 2021
2.3 years
June 11, 2019
October 22, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Middle cerebral artery flow velocity (MCAv) + induced hypertension
Measuring MCAv after induced hypertension
within 5 days after ictus, for 10 minutes after steady state
Secondary Outcomes (6)
Intracranial pressure (ICP) + induced hypertension
within 5 days after ictus
Partial brain tissue oxygenation (PbtO2) + induced hypertension
within 5 days after ictus
Intracranial pressure (ICP) + hyper- and hypocapnia
within 5 days after ictus, for 10 minutes after steady state
Partial brain tissue oxygenation (PbtO2) + hyper- and hypocapnia
within 5 days after ictus, for 10 minutes after steady state
Intracranial pressure (ICP) + hyper- and hypoxia
within 5 days after ictus, for 10 minutes after steady state
- +1 more secondary outcomes
Study Arms (1)
All patients
OTHERPatients included in the study.
Interventions
Hypertension is induced by an infusion of noradrenaline within acceptable limits Baseline recording (10 minutes) is performed. MAP gradually increases in steps of 5-10 mmHg during ongoing TCD. When the desired maximum MAP is reached, measurement is made at steady state (10 minutes). Noradrenaline infusion is stopped. When MAP is stabilized, new baseline is measured for 10 minutes.
The mechanical ventilator is adjusted to mild hypoxia, normoxia and mild hyperoxia. Measurements are made for 10 minutes at normoxia and after steady state is reached, respectively. hyperoxia and hypoxia. Oxygenation is controlled by arterial blood gas before and during steady state.
The mechanical ventilator is adjusted to a delta PaCO2 on the ventilator for both hypocapnia and hypercapnia. Measurements are made for 10 minutes at normocapnia and after steady state is reached, respectively. hyper- and hypocapnia.
Eligibility Criteria
You may qualify if:
- Admittance to neurointensive care unit, Rigshospitalet
- Age ≥ 18 years old
- Aneurysmal subarachnoid haemorrhage
- Clinical indication for placement of an external ventricular drain
- Measurements can be done within 3 days of ictus
- Closest relatives understand written and spoken danish
You may not qualify if:
- No aneurysm identified
- Conservative og failed treatment of aneurysm
- Pupils dilated and do not react to light
- Expected death within 48 hours
- Acute or chronic diseases associated with impaired autoregulation
- Severe chronic lung failure with a PaCO2 \> 6.5 kPa or PaO2 \< 8 kPa.
- Age ≥ 18 years old;
- Understands written and spoken danish
- Oral and written consent
- No medication expect hay fever medications
- Alcohol consumption within the limits from the danish health care board
- Healthy without previous or current cerebrovascular diseases
- Insonation is possible from the middle cerebral artery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Neuroanaesthesiology
Copenhagen, Capital Region, 2200, Denmark
Related Publications (23)
Kurian MA, Li Y, Zhen J, Meyer E, Hai N, Christen HJ, Hoffmann GF, Jardine P, von Moers A, Mordekar SR, O'Callaghan F, Wassmer E, Wraige E, Dietrich C, Lewis T, Hyland K, Heales S Jr, Sanger T, Gissen P, Assmann BE, Reith ME, Maher ER. Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study. Lancet Neurol. 2011 Jan;10(1):54-62. doi: 10.1016/S1474-4422(10)70269-6. Epub 2010 Nov 25.
PMID: 21112253BACKGROUNDOlsen MH, Orre M, Leisner ACW, Rasmussen R, Bache S, Welling KL, Eskesen V, Moller K. Delayed cerebral ischaemia in patients with aneurysmal subarachnoid haemorrhage: Functional outcome and long-term mortality. Acta Anaesthesiol Scand. 2019 Oct;63(9):1191-1199. doi: 10.1111/aas.13412. Epub 2019 Jun 7.
PMID: 31173342BACKGROUNDvan Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet. 2007 Jan 27;369(9558):306-18. doi: 10.1016/S0140-6736(07)60153-6.
PMID: 17258671BACKGROUNDBrathwaite S, Macdonald RL. Current management of delayed cerebral ischemia: update from results of recent clinical trials. Transl Stroke Res. 2014 Apr;5(2):207-26. doi: 10.1007/s12975-013-0316-8. Epub 2013 Dec 13.
PMID: 24338266BACKGROUNDSchmidt JM, Wartenberg KE, Fernandez A, Claassen J, Rincon F, Ostapkovich ND, Badjatia N, Parra A, Connolly ES, Mayer SA. Frequency and clinical impact of asymptomatic cerebral infarction due to vasospasm after subarachnoid hemorrhage. J Neurosurg. 2008 Dec;109(6):1052-9. doi: 10.3171/JNS.2008.109.12.1052.
PMID: 19035719BACKGROUNDDankbaar JW, Slooter AJ, Rinkel GJ, Schaaf IC. Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review. Crit Care. 2010;14(1):R23. doi: 10.1186/cc8886. Epub 2010 Feb 22.
PMID: 20175912BACKGROUNDRoos YB, de Haan RJ, Beenen LF, Groen RJ, Albrecht KW, Vermeulen M. Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in the Netherlands. J Neurol Neurosurg Psychiatry. 2000 Mar;68(3):337-41. doi: 10.1136/jnnp.68.3.337.
PMID: 10675216BACKGROUNDDorhout Mees SM, Kerr RS, Rinkel GJ, Algra A, Molyneux AJ. Occurrence and impact of delayed cerebral ischemia after coiling and after clipping in the International Subarachnoid Aneurysm Trial (ISAT). J Neurol. 2012 Apr;259(4):679-83. doi: 10.1007/s00415-011-6243-2. Epub 2011 Sep 24.
PMID: 21947244BACKGROUNDBudohoski KP, Czosnyka M, Kirkpatrick PJ, Smielewski P, Steiner LA, Pickard JD. Clinical relevance of cerebral autoregulation following subarachnoid haemorrhage. Nat Rev Neurol. 2013 Mar;9(3):152-63. doi: 10.1038/nrneurol.2013.11. Epub 2013 Feb 19.
PMID: 23419369BACKGROUNDMacdonald RL. Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol. 2014 Jan;10(1):44-58. doi: 10.1038/nrneurol.2013.246. Epub 2013 Dec 10.
PMID: 24323051BACKGROUNDLASSEN NA. Cerebral blood flow and oxygen consumption in man. Physiol Rev. 1959 Apr;39(2):183-238. doi: 10.1152/physrev.1959.39.2.183. No abstract available.
PMID: 13645234BACKGROUNDBerg, R.M.G., Pedersen, M., Møller, K.: Static cerebral blood flow autoregulation in humans. Curr. Hypertens. Rev. 5, 140-157 (2009).
BACKGROUNDCzosnyka M, Smielewski P, Piechnik S, Steiner LA, Pickard JD. Cerebral autoregulation following head injury. J Neurosurg. 2001 Nov;95(5):756-63. doi: 10.3171/jns.2001.95.5.0756.
PMID: 11702864BACKGROUNDEames PJ, Blake MJ, Dawson SL, Panerai RB, Potter JF. Dynamic cerebral autoregulation and beat to beat blood pressure control are impaired in acute ischaemic stroke. J Neurol Neurosurg Psychiatry. 2002 Apr;72(4):467-72. doi: 10.1136/jnnp.72.4.467.
PMID: 11909905BACKGROUNDStrauss G, Hansen BA, Knudsen GM, Larsen FS. Hyperventilation restores cerebral blood flow autoregulation in patients with acute liver failure. J Hepatol. 1998 Feb;28(2):199-203. doi: 10.1016/0168-8278(88)80006-0.
PMID: 9514532BACKGROUNDMoller K, Skinhoj P, Knudsen GM, Larsen FS. Effect of short-term hyperventilation on cerebral blood flow autoregulation in patients with acute bacterial meningitis. Stroke. 2000 May;31(5):1116-22. doi: 10.1161/01.str.31.5.1116.
PMID: 10797174BACKGROUNDOtite F, Mink S, Tan CO, Puri A, Zamani AA, Mehregan A, Chou S, Orzell S, Purkayastha S, Du R, Sorond FA. Impaired cerebral autoregulation is associated with vasospasm and delayed cerebral ischemia in subarachnoid hemorrhage. Stroke. 2014 Mar;45(3):677-82. doi: 10.1161/STROKEAHA.113.002630. Epub 2014 Jan 14.
PMID: 24425120BACKGROUNDBudohoski KP, Czosnyka M, Kirkpatrick PJ, Reinhard M, Varsos GV, Kasprowicz M, Zabek M, Pickard JD, Smielewski P. Bilateral failure of cerebral autoregulation is related to unfavorable outcome after subarachnoid hemorrhage. Neurocrit Care. 2015 Feb;22(1):65-73. doi: 10.1007/s12028-014-0032-6.
PMID: 25056137BACKGROUNDMa X, Willumsen L, Hauerberg J, Pedersen DB, Juhler M. Effects of graded hyperventilation on cerebral blood flow autoregulation in experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2000 Apr;20(4):718-25. doi: 10.1097/00004647-200004000-00009.
PMID: 10779016BACKGROUNDRamakrishna R, Stiefel M, Udoetuk J, Spiotta A, Levine JM, Kofke WA, Zager E, Yang W, Leroux P. Brain oxygen tension and outcome in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg. 2008 Dec;109(6):1075-82. doi: 10.3171/JNS.2008.109.12.1075.
PMID: 19035722BACKGROUNDSkjoth-Rasmussen J, Schulz M, Kristensen SR, Bjerre P. Delayed neurological deficits detected by an ischemic pattern in the extracellular cerebral metabolites in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg. 2004 Jan;100(1):8-15. doi: 10.3171/jns.2004.100.1.0008.
PMID: 14743906BACKGROUNDRoh DJ, Morris NA, Claassen J. Intracranial Multimodality Monitoring for Delayed Cerebral Ischemia. J Clin Neurophysiol. 2016 Jun;33(3):241-9. doi: 10.1097/WNP.0000000000000277.
PMID: 27258448BACKGROUNDOlsen MH, Capion T, Riberholt CG, Bache S, Ebdrup SR, Rasmussen R, Mathiesen T, Berg RMG, Moller K. Effect of controlled blood pressure increase on cerebral blood flow velocity and oxygenation in patients with subarachnoid haemorrhage. Acta Anaesthesiol Scand. 2023 Sep;67(8):1054-1060. doi: 10.1111/aas.14277. Epub 2023 May 16.
PMID: 37192754DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Fellow
Study Record Dates
First Submitted
June 11, 2019
First Posted
June 14, 2019
Study Start
June 15, 2019
Primary Completion
October 1, 2021
Study Completion
March 1, 2022
Last Updated
October 29, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- The approved study protocol will be available upon request until publication of the study results
- Access Criteria
- Valid reason and contact with author
Data from each individual participant will be available after publication of planned manuscripts, with a valid reason, and after signing a data processing agreement.